Cargando…
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
As the COVID-19 pandemic is affecting the lives of thousands of people worldwide, the problem of timely access to affordable medicines has intensified today. Based on past experience of accessing medicines for life-threatening diseases there is a justifiable fear that access to any vaccines and trea...
Autor principal: | Gurgula, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592140/ https://www.ncbi.nlm.nih.gov/pubmed/33132411 http://dx.doi.org/10.1007/s40319-020-00985-0 |
Ejemplares similares
-
Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry
por: Song, Chie Hoon, et al.
Publicado: (2016) -
Patent foramen ovale and migraine: no reason to intervene
por: Diener, Hans-Christoph
Publicado: (2007) -
The Goodyear Company's Patent
Publicado: (1879) -
Patents and Strategic Inventing: The Corporate Inventor's Guide to Creating Sustainable Competitive Advantage
por: Nissing, Nicholas
Publicado: (2012) -
Dynamics of price competition in Italian pharmaceutical off-patent market
por: Perna, Serena, et al.
Publicado: (2022)